lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
260 rows where filing_period = "second_quarter", filing_year = 2012 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, income_amount, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1257142 | CHARLIE MCBRIDE ASSOCIATES 015062f9-4831-447e-894d-380818b6a2e1 | Q2 | CHARLIE MCBRIDE ASSOCIATES | 24214 | BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA | 2012 | second_quarter | MED | To monitor legislation affecting medical energy research and technology-based economic development | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-06-15T15:46:44.583000-04:00 | |
| 1257174 | OGR a70765b0-41d2-4a68-b37d-0e0d42b2def1 | Q2 | OGR | 48827 | ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | 2012 | second_quarter | MED | Medical Device User Fee Act and related issues | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-06-18T11:03:32.377000-04:00 | |
| 1257486 | PARALYZED VETERANS OF AMERICA 4c3adf07-bee6-4ab8-ab58-526bb8b7b69e | Q2 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2012 | second_quarter | MED | Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA) | 83249 | 0 | 0 | 2012-06-29T11:27:08.117000-04:00 | |
| 1257869 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 340b4753-f1a3-4e66-8f94-074a909d1181 | Q2 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | VIJUK EQUIPMENT, INC. | 2012 | second_quarter | MED | all matters dealing with pharmaceutical labeling | Food & Drug Administration (FDA) | 25000 | 0 | 0 | 2012-07-03T10:25:36.937000-04:00 | |
| 1257896 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 6dc668bf-df49-4fdf-a1fd-fbcccb1db8c3 | Q2 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2012 | second_quarter | MED | AACC contacted House leaders to support provisions Sections 721 and 203(f) of H.R.5651, Food and Drug Administration Reform Act of 2012, which sought to streamline the FDA de novo medical device review process and give the HHS Secretary authority to waive FDA medical device user fees in the interest of public health. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-03T10:56:49.673000-04:00 | ||
| 1258012 | WAKE FOREST UNIVERSITY HEALTH SCIENCES badf2a52-a5cd-4e7d-ac05-1f55de0a6804 | Q2 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2012 | second_quarter | MED | NIH Budget including Title VII & VIII programs VA-Outpatient Clinic in N.C.(RFP-land acquisition) | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 145000 | 0 | 0 | 2012-07-03T13:43:15.167000-04:00 | |
| 1258099 | UNIVERSITY OF IOWA d38dbbed-253f-4ab8-a41a-f0a1eb5e397c | Q2 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2012 | second_quarter | MED | FY 2011 Appropriations Residency Caps FY 2012 Appropriations Minority Improvement Medical Affordability Act False Claims Correction Act Research Misconduct Clinical Trials NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act Prevention Research Centers Resident Physician Shortage Health Care Reform FY 2013 Appropriations | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 88684 | 0 | 0 | 2012-07-03T16:59:14.913000-04:00 | |
| 1258217 | THE HARRIS FIRM 783a0b90-0c66-44b7-9343-5d1fee453509 | Q2 | THE HARRIS FIRM | 68376 | DIRECT MESSAGE LAB | 2012 | second_quarter | MED | Regarding funding pertaining to software communication system for chronic disease management. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-05T12:51:47.947000-04:00 | ||
| 1258258 | MARSHALL BRACHMAN 40042197-7268-418b-a143-3d12806d5ae0 | Q2 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2012 | second_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2012-07-05T13:48:06.717000-04:00 | |
| 1258286 | STANFORD UNIVERSITY 83ea2395-df24-4c53-9618-3098df517882 | Q2 | STANFORD UNIVERSITY | 36492 | STANFORD UNIVERSITY | 2012 | second_quarter | MED | Stem Cell Research Policy HR2376 Stem Cell Research Advancement Act | Defense, Dept of (DOD),Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE | 100000 | 0 | 0 | 2012-07-05T14:05:17.880000-04:00 | |
| 1258379 | AMERICAN COLLEGE OF CLINICAL PHARMACY 8d8da5a7-ba19-4f0b-8d4d-e341a6483704 | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2012 | second_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 61700 | 0 | 0 | 2012-07-05T15:08:09.390000-04:00 | |
| 1258511 | FEDERAL SOLUTIONS, LLC a7cac74b-e5af-4549-8507-b113423cc1f7 | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | JACKSONVILLE STATE UNIVERSITY | 2012 | second_quarter | MED | Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research, education, and development | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-06T10:32:18.643000-04:00 | |
| 1258530 | FEDERAL SOLUTIONS, LLC 0887054f-fef8-4183-9a70-b04e06be663c | Q2 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2012 | second_quarter | MED | Labor/HHS/Education Appropriations Bill 2012: Provisions relating to disease research | Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2012-07-06T10:35:21.627000-04:00 | |
| 1258741 | FRANCIS EDWARD & CRONIN, INC. 4d07dc8a-8c0d-48bc-92bc-e31b54c23818 | Q2 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2012 | second_quarter | MED | Legislation and issues related to Alzheimer's Disease Research | Defense, Dept of (DOD),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl AIDS Policy,Office of Science & Technology Policy (OSTP),SENATE,White House Office | 10000 | 0 | 0 | 2012-07-08T16:38:00.400000-04:00 | |
| 1259461 | RAY C CULVER III 2289e79a-388c-495e-bee0-743252b7a1a9 | Q2 | RAY C CULVER III | 11468 | ARKANSAS CHILDREN'S HOSPITAL | 2012 | second_quarter | MED | Funding for USDA Agricultural Research Service human nutrition centers in the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill, 2013, and authorization language in the Senate Agriculture Reform, Food and Jobs Act of 2012 and the House Federal Agriculture Reform and Risk Management Act of 2012 | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-07-10T00:11:55.970000-04:00 | |
| 1259911 | PALMETTO GROUP 62968d14-bf89-4a3c-b906-4ad986803af1 | Q2 | PALMETTO GROUP | 18570 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2012 | second_quarter | MED | Federal Funding of AIDS vaccine S.1601 Department of State, Foreign Operations, and Related Programs Appropriations Act, 2012 | SENATE | 22500 | 0 | 0 | 2012-07-10T16:15:07.037000-04:00 | |
| 1260174 | KSCW, INC. 6efba89e-0c2c-4032-907b-51ef9c548cf6 | Q2 | KSCW, INC. | 21596 | INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS | 2012 | second_quarter | MED | S.3187: Food and Drug Administration Safety and Innovation Act, Provisions affecting the Medical device industry H.R.436: Health Care Cost Reduction Act of 2012 provisions related to the medical device excise tax S.262 A bill to repeal the excise tax on medical device manufacturers. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-07-11T11:05:43.703000-04:00 | |
| 1260654 | DENNY MILLER ASSOCIATES bdd45747-b59c-495d-8596-8f713efb7291 | Q2 | DENNY MILLER ASSOCIATES | 25328 | CELL THERAPEUTICS | 2012 | second_quarter | MED | S. 3187, Food and Drug Administration Safety and Innovation Act of 2012, provisions relating to the approval of new drugs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-11T16:22:16.397000-04:00 | |
| 1260661 | PARRY, ROMANI, DECONCINI & SYMMS 67ab2707-0f05-48ae-a31e-862816c93828 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AIDS HEALTHCARE FOUNDATION | 2012 | second_quarter | MED | Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 - Support funding for medical treatment for HIV positive patients. Support appropriate funding for the ADAP program. Continue appropriate funding for Chronic Care Special Needs clinics under Medicare. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-11T16:35:20.333000-04:00 | |
| 1260840 | THE PETRIZZO GROUP, INC. 718fe664-97b0-4483-9409-8cfcc7e3ba32 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | FRED HUTCHINSON CANCER RESEARCH CENTER | 2012 | second_quarter | MED | Advocated for funding for the National Institutes of Health and National Cancer Institute for FY 2013 funding. Advocated for funding by USAID for the Uganda Program on Cancer & Infectious Diseases. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-12T09:49:14.003000-04:00 | |
| 1260858 | TAUZIN CONSULTANTS, LLC f87f2484-6678-45f8-8c02-9b62094936a9 | Q2 | TAUZIN CONSULTANTS, LLC | 400671007 | RESILIENT NETWORK SYSTEMS, INC. | 2012 | second_quarter | MED | Cross-agency research and collaboration for R&D, clinical trials and recruitment. | Director of National Intelligence (ODNI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2012-07-12T09:59:11-04:00 | |
| 1260868 | THE PETRIZZO GROUP, INC. 01e51ac6-10b7-4923-9b8f-526051e95362 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | MVP SERVICE CORP. | 2012 | second_quarter | MED | Advocated concerns with negative consequences of the Patient Protection and Affordable Care Act (ACA), specifically 1) new taxes that will cause premium increases and raise cost of health care coverage; 2) cuts to Medicare Advantage funding; 3)weak individual mandate resulting in adverse selection; 4) HHS proposed regulation that omits fraud and abuse prevention, concurrent review and costs associated with the federally-mandated ICD-10 program from health care quality improvement programs. Encouraged Members to co-sponsor a bill (H.R. 1370) introduced by Representative Boustany (R-LA) that would repeal the Small-Business Health Insurance Tax (HIT) enacted by the Affordable Care Act (ACA). Raised awareness about the impact of significant funding cuts included in the ACA and encourages Congress to restore the MA program funding to pre-ACA levels. Encouraged Members to co-sponsor the bipartisan Medicare Beneficiary Preservation Act of 2011 (H.R. 1580/S. 1479), which was introduced by Representatives Gonzalez (D-TX) and Buchanan (R-FL) and Senators Casey (D-PA) and Toomey (R-PA). This bill would provide a backstop for Medicare enrollees to find a suitable health plan by repealing ACA changes to MA open enrollment dates that limit beneficiary choice and flexibility. The bill would also lengthen open enrollment periods and allowas was the case before ACA changesenrollees to change from an MA plan to the original fee-for-service plan, or vice versa, or to a more suitable MA plan once a year during the first three months. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-07-12T10:03:29.683000-04:00 | |
| 1260885 | THE PETRIZZO GROUP, INC. 55ad924c-2a70-494a-b54e-19155286021c | Q2 | THE PETRIZZO GROUP, INC. | 305932 | ORLANDO HEALTH | 2012 | second_quarter | MED | Concerns with issues around the Medicaid expansion of the ACA and Disproportionate Share Hospital (DSH) cuts. Concerns with issues regarding Medicaid being used as an offset for tax cuts and sequestration. | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2012-07-12T10:12:43.243000-04:00 | |
| 1260895 | THE PETRIZZO GROUP, INC. 8f911f37-f8f9-4586-a0cb-15d9cc2d3782 | Q2 | THE PETRIZZO GROUP, INC. | 305932 | SAGE THERAPEUTICS, INC. | 2012 | second_quarter | MED | Advocated for federal funding to support development of neuroactive steroids research yielding therapeutics with a core focus on Traumatic Brain Injury (TBI), Post-Traumatic Stress Disorder (PTSD), and Pain. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-12T10:23:48.893000-04:00 | |
| 1261074 | TURNER & GOSS LLP d15a28bd-b85a-4687-9020-4ab15ad7971f | Q2 | TURNER & GOSS LLP | 316310 | CYSTIC FIBROSIS FOUNDATION | 2012 | second_quarter | MED | Food and Drug Administration Safety and Innovation Act, including provisions of the Expanding and Promoting Exertise in Review of Rare Treatments Act of 2012 (S. 2281/HR 4156) as incorporated in the Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-12T12:35:32.277000-04:00 | |
| 1261079 | TURNER & GOSS LLP b23da46a-4741-474e-a9be-6819748f42c9 | Q2 | TURNER & GOSS LLP | 316310 | CANCER LEADERSHIP COUNCIL | 2012 | second_quarter | MED | Drug shortage provisions as included in the Food and Drug Administration Safety and Innovation Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-12T12:40:36.023000-04:00 | ||
| 1261081 | TURNER & GOSS LLP 59196aab-e20d-4c3e-a13a-5eb064fe38d8 | Q2 | TURNER & GOSS LLP | 316310 | LYMPHOMA RESEARCH FOUNDATION | 2012 | second_quarter | MED | Drug shortage provisions of the Food and Drug Administration Safety and Innovation Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-12T12:45:36.867000-04:00 | ||
| 1261089 | TURNER & GOSS LLP 691a1173-9935-4156-97c1-cce7f776c496 | Q2 | TURNER & GOSS LLP | 316310 | LEUKEMIA & LYMPHOMA SOCIETY | 2012 | second_quarter | MED | Drug shortage provisions of Food and Drug Administration Safety and Innovation Act | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-07-12T12:51:40.520000-04:00 | |
| 1261091 | TURNER & GOSS LLP f0f95e7e-48b5-426d-9aa0-8c575f017808 | Q2 | TURNER & GOSS LLP | 316310 | NATIONAL COALITION FOR CANCER SURVIVORSHIP | 2012 | second_quarter | MED | Drug shortage provisions of Food and Drug Administration Safety and Innovation Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-12T12:57:42.457000-04:00 | ||
| 1261135 | THOMPSON HINE LLP 23274b52-57a1-423b-89b2-8c97d8e75830 | Q2 | THOMPSON HINE LLP | 38051 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 2012 | second_quarter | MED | Legislative and regulatory matters regarding the use of chimpanzees in biomedical research (i.e., the Great Ape Protection and Cost Savings Act and possible "endangered species" designation for chimpanzees by the U.S. Fish and Wildlife Service). | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-07-12T14:20:07.780000-04:00 | |
| 1261292 | PARRY, ROMANI, DECONCINI & SYMMS e2fa8db2-aa81-42ad-9ace-ec874e6285b7 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2012 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-07-12T16:58:31.483000-04:00 | |
| 1261301 | PARRY, ROMANI, DECONCINI & SYMMS ef702ed0-4326-44a6-aabd-1688e8451258 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2012 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2012-07-12T17:05:35.747000-04:00 | |
| 1261350 | PARRY, ROMANI, DECONCINI & SYMMS bbf34b52-4b5b-4173-a16b-68ba45116eb9 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2012 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-07-12T17:25:57.753000-04:00 | |
| 1261377 | PARRY, ROMANI, DECONCINI & SYMMS 347c89ec-f95a-41a1-a32d-649aa6766f94 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2012 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-07-12T17:33:07.937000-04:00 | |
| 1261392 | PARRY, ROMANI, DECONCINI & SYMMS 52b94dbf-16a3-4867-840f-7092121257d9 | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2012 | second_quarter | MED | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-07-12T17:41:15.013000-04:00 | |
| 1261565 | BEN BARNES GROUP LP 68a55e10-2c50-4c0a-b211-bd34a8be5cba | Q2 | BEN BARNES GROUP LP | 5415 | FAIR LABORATORY PRACTICES ASSOCIATION | 2012 | second_quarter | MED | Bring attention to prevention of unfair billing practices by laboratories for Medicare services | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-13T09:47:19.770000-04:00 | |
| 1261844 | DALRYMPLE & ASSOCIATES, LLC 0c66fce2-9a02-407c-8df7-5bee6d470ea1 | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | SANOFI PASTEUR | 2012 | second_quarter | MED | Vaccine research and development legislation, funding, appropriations and oversight. | Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office | 46000 | 0 | 0 | 2012-07-13T11:53:18.190000-04:00 | |
| 1261876 | DALRYMPLE & ASSOCIATES, LLC bcd3e5dd-ccc5-427d-8d6e-6274a7b86baf | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION) | 2012 | second_quarter | MED | Biodefense and naturally-occurring vaccine and related biological therapeutic products and civilian oncology therapeutic products research and development funding, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 46000 | 0 | 0 | 2012-07-13T11:59:31.250000-04:00 | |
| 1261909 | DALRYMPLE & ASSOCIATES, LLC f2d03b67-cecb-4e64-9c17-7ae4d0b6c23b | Q2 | DALRYMPLE & ASSOCIATES, LLC | 5073 | DISCOVERY LABORATORIES | 2012 | second_quarter | MED | Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight. | Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 16000 | 0 | 0 | 2012-07-13T12:04:40.623000-04:00 | |
| 1262275 | BEN BARNES GROUP LP ccac1488-5052-4a7a-b5cb-70fd0390d5d1 | Q2 | BEN BARNES GROUP LP | 5415 | OKLAHOMA RESEARCH MEDICAL FOUNDATION | 2012 | second_quarter | MED | Medical Research Funding | HOUSE OF REPRESENTATIVES,SENATE | 20100 | 0 | 0 | 2012-07-13T15:12:11.107000-04:00 | |
| 1262547 | OREGON STATE UNIVERSITY 4cc70a7f-baab-41cc-ac56-77116e49a2a0 | Q2 | OREGON STATE UNIVERSITY | 309390 | OREGON STATE UNIVERSITY | 2012 | second_quarter | MED | HR 3433, the GRANT Act- advocated for a balanced approach to publication of competitive grant proposals and processes. S. 968, the Protect IP Act and HR 3261 the Stop Online Privacy Act. H.R.5037 or S.1373 the Federal Research Public Access Act.Data Act 2146. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-07-13T17:23:56.943000-04:00 | |
| 1262557 | BEN BARNES GROUP LP c2e5bb4a-fe59-4b3f-b502-98c5fc48b637 | Q2 | BEN BARNES GROUP LP | 5415 | ROYALTY PHARMA - / RP MANAGEMENT, LLC | 2012 | second_quarter | MED | Matters pertaining to the Stop Internet Piracy Act and other legislation related to internet security | HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2012-07-13T17:25:58.570000-04:00 | |
| 1262680 | SQUIRE PATTON BOGGS 29214ecf-1260-4c3d-928f-e74f59eac9e2 | Q2 | SQUIRE PATTON BOGGS | 30906 | GENENTECH, INC. | 2012 | second_quarter | MED | Implementation of healthcare reform law. FDA drug approval and appeal oversight process. Issues related to patient and physician choice in medical treatments. PDUFA reauthorization. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2012-07-14T10:04:28.880000-04:00 | |
| 1262744 | BEN BARNES GROUP LP 07968fd8-02da-4632-8363-4789058ee15d | Q2 | BEN BARNES GROUP LP | 5415 | TEXAS A&M SYSTEM | 2012 | second_quarter | MED | Assist the Texas A&M System in pursuit of various projects, general government relations | Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 37500 | 0 | 0 | 2012-07-14T12:13:20.810000-04:00 | |
| 1262915 | BRACEWELL LLP 9b2b7715-455c-4f98-a87f-9f7bf126eb4a | Q2 | BRACEWELL LLP | 6837 | AIR LIQUIDE USA LLC | 2012 | second_quarter | MED | Worked related to the Medical Gas Safety Act | Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Treasury, Dept of | 60000 | 0 | 0 | 2012-07-15T13:17:34.087000-04:00 | |
| 1263258 | VAN SCOYOC ASSOCIATES 33a9b221-9a08-4b59-8a14-7451a3c1a136 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | ELECTROCHEMICAL OXYGEN CONCEPTS, INC. DBA EO2 CONCEPTS | 2012 | second_quarter | MED | No lobbying activity. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-16T06:30:12.037000-04:00 | |
| 1263381 | VAN SCOYOC ASSOCIATES 43acb245-ed68-4331-a035-8df106f6094d | Q2 | VAN SCOYOC ASSOCIATES | 39837 | MEDICINES FOR MALARIA VENTURE | 2012 | second_quarter | MED | USAID and Malaria research and development issues and initiatives | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-16T07:20:00.197000-04:00 | |
| 1263528 | VENABLE LLP 765e2462-8937-46b3-81fa-288d54b95ac4 | Q2 | VENABLE LLP | 39941 | AMPHASTAR PHARMACEUTICALS INC. | 2012 | second_quarter | MED | Primatene Mist Sunset Date | Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-16T08:50:38.570000-04:00 | |
| 1263663 | CORNERSTONE GOVERNMENT AFFAIRS, INC. c6ac1098-c908-466c-992e-8a42b1033920 | Q2 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | PATH | 2012 | second_quarter | MED | Monitor issues related to global health and technology. Track USG activity and expenditures on medical research and development. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-07-16T10:02:48.663000-04:00 | |
| 1263679 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c45c6b19-63cc-43d3-b377-73f1d86e899b | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2012 | second_quarter | MED | No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, Tuberous Sclerosis HR 5856, Defense Appropriations, FY 2013 Defense health programs, Tuberous Sclerosis Complex Research Program | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2012-07-16T10:09:59.383000-04:00 | |
| 1263719 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4a79cc1a-d64d-481d-8f66-28bfb8e5317b | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | SAGE PUBLICATIONS, INC. | 2012 | second_quarter | MED | HR4004, S.2096, Federal Research Public Access Act; National Institutes of Health Open Access policy No Bill#, America COMPETES Act, implementation of public access policy at federal science agencies No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, NIH Open Access Policy, Department of Education Title II Funding HR3699, Research Works Act No Bill#, Reauthorization of Elementary and Secondary Education Act, Title II Funding | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-16T10:24:14.573000-04:00 | |
| 1263819 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a56f7bf4-404c-48fd-9639-7e29af43d297 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION | 2012 | second_quarter | MED | No Bill #, Labor-HHS-Education Appropriations Bill, FY 2013, biomedical research HR 5856, Defense Appropriations Bill, FY 2013, defense health programs, research for bone marrow failure disease HR 640, Bone Marrow Failure Disease Research and Treatment Act | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2012-07-16T11:08:58.627000-04:00 | |
| 1263825 | SRI INTERNATIONAL ccbeb09c-fb48-45b8-9ec8-a5d7974f3e8e | Q2 | SRI INTERNATIONAL | 90990 | SRI INTERNATIONAL | 2012 | second_quarter | MED | Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 (HR 2405, S 1855) FY 13 House and Senate Labor/HHS/Education Appropriations (S 3295) | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2012-07-16T11:10:00.770000-04:00 | |
| 1263867 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 43c02fe4-5b81-4539-9889-17e4e4b13622 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2012 | second_quarter | MED | Issues impacting the legislative and regulatory oversight of laboratory developed tests, reimbursement of diagnostic tests, DNA patents, workforce issues, standards development for diagnostics. No Bill#: Genomics and Personalized Medicine Act; No Bill#: Genomic Research and Accessibility Act; No Bill#: BETTER Patient Care; HR 3207: Modernizing Laboratory Test Standards for Patients Act; HR 3497 MODDERN Cures Act | Agency for Healthcare Research & Quality (AHRQ),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 30000 | 0 | 0 | 2012-07-16T11:26:25.080000-04:00 | |
| 1264069 | MEHLMAN CONSULTING, INC. a40be5bb-9281-4015-b028-b45344fa5a88 | Q2 | MEHLMAN CONSULTING, INC. | 284950 | AMERICAN CLINICAL LABORATORY ASSOCIATION | 2012 | second_quarter | MED | Health reform law implementation issues including application of medical device tax to clinical laboratory tests and laboratory fee schedule. In-office ancillary services exception to Stark Law. H.R. 3207, The Modernizing Laboratory Test Standards for Patients Act. H.R. 5651, Food and Drug Administration Reform Act S. 3187, Food and Drug Administration Safety and Innovation Act. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 60000 | 0 | 0 | 2012-07-16T13:15:06.857000-04:00 | |
| 1264100 | TCH GROUP, LLC 9dfb87db-be69-4803-8436-3e52bf5fd892 | Q2 | TCH GROUP, LLC | 51478 | SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) | 2012 | second_quarter | MED | General discussion regarding the reauthorization of the Prescription Drug User Fee Act (PDUFA) | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-07-16T13:26:26.327000-04:00 | |
| 1264117 | GRIZZLE COMPANY bbc59413-d265-469a-aef5-448990a48f1f | Q2 | GRIZZLE COMPANY | 16987 | UNIVERSITY OF LOUISVILLE | 2012 | second_quarter | MED | Request support for NIH grant application | 40000 | 0 | 0 | 2012-07-16T13:32:38.440000-04:00 | ||
| 1264176 | DIALYSIS PATIENT CITIZENS a513eaac-6ed7-4c60-a5d7-ca8d8ebd5d44 | Q2 | DIALYSIS PATIENT CITIZENS | 400460287 | DIALYSIS PATIENT CITIZENS | 2012 | second_quarter | MED | Supporting innovative pilots to reduce and potentially prevent ESRD Importance of anemia management for ESRD patients Prioritizing patient role in infection prevention efforts at dialysis facilities Prioritize patient safety in developing procedure for approval of "generic" IV Iron | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office | 25000 | 0 | 0 | 2012-07-16T13:54:05.347000-04:00 | |
| 1264277 | MEHLMAN CONSULTING, INC. bd5f104d-08e6-49ee-822f-23efecfa8f22 | Q2 | MEHLMAN CONSULTING, INC. | 284950 | NATIONAL VENTURE CAPITAL ASSOCIATION | 2012 | second_quarter | MED | FDA reform: Changes to PDUFA (Prescription Drug User Fee Act) and MDUFA (Medical Device User Fee Act) programs. H.R. 4132, Faster Access to Specialized Treatments (FAST) Act; S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act; H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act of 2011; S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012 (See continuation page) H.R. 5651, Food and Drug Administratioin Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. | Executive Office of the President (EOP),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 60000 | 0 | 0 | 2012-07-16T14:23:54.053000-04:00 | |
| 1264296 | DANIELLE ORGAN PETERS ea847f0c-2aec-43ea-9d2b-58188e35f6fd | Q2 | DANIELLE ORGAN PETERS | 400427062 | FABIANI & COMPANY ON BEHALF OF MEDICAGO | 2012 | second_quarter | MED | Influenza vaccine R&D and production | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-16T14:32:04.117000-04:00 | ||
| 1264592 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS bfd4bd2d-6401-4cd0-9069-5a1fc4dfcce2 | Q2 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 1375 | AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 2012 | second_quarter | MED | Improving health quality measures and enhancing the activities of the Agency for Health Research and Quality (AHRQ) | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),SENATE | 156340 | 0 | 0 | 2012-07-16T15:58:45.243000-04:00 | |
| 1264620 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9f454ef9-b9a3-4905-b681-c0bdf13bdcb5 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | STATE UNIVERSITY SYSTEM OF FLORIDA | 2012 | second_quarter | MED | Appropriations and Authorization legislation for FY 2013 in health care | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE | 70000 | 0 | 0 | 2012-07-16T16:03:58.797000-04:00 | |
| 1264631 | LIFE TECHNOLOGIES CORPORATION bfade1d7-9636-4531-82b5-d47d0c50fdad | Q2 | LIFE TECHNOLOGIES CORPORATION | 400391833 | LIFE TECHNOLOGIES CORPORATION | 2012 | second_quarter | MED | H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. | HOUSE OF REPRESENTATIVES,SENATE | 185000 | 0 | 0 | 2012-07-16T16:06:03.223000-04:00 | |
| 1264667 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 59cf3bcb-a908-46a4-8754-9dc36df67f18 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TETHYS BIOSCIENCE | 2012 | second_quarter | MED | Regulation and reimbursement of laboratory developed tests. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-16T16:17:21.067000-04:00 | |
| 1264713 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. edca2026-adac-45ad-a597-a6c424dae5f5 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | INTERNATIONAL MYELOMA FOUNDATION | 2012 | second_quarter | MED | HR 2746 Cancer Drug Coverage Parity Act; HR 2245/S.296 Preserving Access to Lifesaving Medications Act S.3187, Food and Drug Administration Safety and Innovation Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-16T16:31:41.907000-04:00 | |
| 1264723 | ASSN OF MEDICAL DEVICE REPROCESSORS 3ef1da76-822d-4fdb-a7b9-d93f59bc382d | Q2 | ASSN OF MEDICAL DEVICE REPROCESSORS | 291732 | ASSN OF MEDICAL DEVICE REPROCESSORS | 2012 | second_quarter | MED | Educated Congressional staff, members of Congress, and other agency officials on the FDA-regulated, third-party reprocessing industry and ongoing efforts to implement similar regulations internationally. Initiated discussions on MDUFA reauthorization. Contacted VA about hospital regulations for reprocessed single-use medical devices. | Commerce, Dept of (DOC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. International Trade Commission (ITC),Veterans Affairs, Dept of (VA) | 20000 | 0 | 0 | 2012-07-16T16:31:44.797000-04:00 | |
| 1264825 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7ce30cde-4670-4055-b9c3-f12f89394f7b | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2012 | second_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 5000 | 0 | 0 | 2012-07-16T16:46:36.520000-04:00 | |
| 1264858 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. fb172deb-3185-4363-8eb0-675d68616c1e | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2012 | second_quarter | MED | Research in hematology. | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2012-07-16T16:55:51.250000-04:00 | |
| 1264889 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2fe1967b-9f42-46b5-9c0c-65b2776de717 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2012 | second_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues. HR1919 Bleeding Disorders Screening Awareness and Further Education Act of 2011 | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2012-07-16T17:00:00.737000-04:00 | |
| 1264895 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. a7e78f06-f20a-4cdf-9ed3-f0ab6a9e261f | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION OF AMERICA'S BLOOD BANKS | 2012 | second_quarter | MED | Blood safety and management issues. HHS Advisory Committee on Blood Safety and Availability. Research related to Biovigilance. | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-07-16T17:04:04.843000-04:00 | |
| 1264988 | MCDERMOTT WILL & SCHULTE LLP e38e2763-3c34-45cf-b6d6-3b3ae0ef21c1 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | MAYO CLINIC | 2012 | second_quarter | MED | Address the safety, health and environmental concerns regarding the transport by railroad of hazardous commodities and coal traffic near the Rochester, Minnesota Mayo Clinic facility. The multi-year Surface Transportation Authorization Act and the House THUD Subcommittee Transportation, Housing and Urban Development Appropriations Bill. | HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) | 30000 | 0 | 0 | 2012-07-16T17:30:45.413000-04:00 | |
| 1265014 | MCDERMOTT WILL & SCHULTE LLP 1fde7ce9-244b-49b6-af75-b2d7f5654044 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ISIS PHARMACEUTICALS | 2012 | second_quarter | MED | Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes. Specifically, work on patent reform legislation, including S. 23 and H.R. 1249. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-16T17:35:55.847000-04:00 | ||
| 1265219 | THE FEDERAL GROUP, INC. bfdad10a-a92d-4b70-845a-d206138728c9 | Q2 | THE FEDERAL GROUP, INC. | 51104 | AMERICAN SOCIETY FOR CLINICAL LABORATORY SCIENCE | 2012 | second_quarter | MED | Issues relating to the regulation of clinical laboratories through the Clinical Laboratory Improvement Act. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-16T23:58:38.143000-04:00 | |
| 1265222 | THE FEDERAL GROUP, INC. 94d66c05-b084-4b3f-8fa5-45e54fb36360 | Q2 | THE FEDERAL GROUP, INC. | 51104 | AMERICAN COLLEGE OF RADIOLOGY | 2012 | second_quarter | MED | Issues relating to mammography screening and standards. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-17T00:35:39.387000-04:00 | |
| 1265377 | THE CJR GROUP, INC. 0022c0f5-a80c-43e4-bbf5-a7cd55eebbe3 | Q2 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2012 | second_quarter | MED | Medical issues relating to hospitals | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-17T09:26:39.060000-04:00 | |
| 1265389 | THE CJR GROUP, INC. af2ed26d-7f24-47f5-b045-8434c9fdef43 | Q2 | THE CJR GROUP, INC. | 288293 | STERIS CORPORATION | 2012 | second_quarter | MED | Biomedical issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-17T09:29:43.257000-04:00 | |
| 1265422 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH bfe630c5-0bd0-41d2-9746-f5113dcca5e5 | Q2 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 314055 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 2012 | second_quarter | MED | Support for the National Eye Institute at the National Institues of Health; Support for medical research programs at the Department of Defense | HOUSE OF REPRESENTATIVES,SENATE | 61500 | 0 | 0 | 2012-07-17T09:49:00.690000-04:00 | |
| 1265470 | MEHLMAN CONSULTING, INC. ec4b750a-190e-4870-8e5e-beadf4bcfe38 | Q2 | MEHLMAN CONSULTING, INC. | 284950 | MAYO CLINIC | 2012 | second_quarter | MED | NIH appropriations Clinical laboratory reimbursement | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-07-17T10:02:23.130000-04:00 | |
| 1265632 | CHILDREN'S HOSPITAL BOSTON d3047021-3572-4b0c-8344-728ab531a088 | Q2 | CHILDREN'S HOSPITAL BOSTON | 9066 | CHILDREN'S HOSPITAL BOSTON | 2012 | second_quarter | MED | Pediatric research issues including clinical effectiveness, development of pediatric research consortia, and specific disease areas. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2012-07-17T10:47:46.887000-04:00 | |
| 1266021 | AMERICAN SOCIETY FOR MICROBIOLOGY f3fbccb5-dba2-4bf7-945a-80778e42ae31 | Q2 | AMERICAN SOCIETY FOR MICROBIOLOGY | 3355 | AMERICAN SOCIETY FOR MICROBIOLOGY | 2012 | second_quarter | MED | Antimicrobial Resistance New Drugs Food and Drug Administration Fee Bill S. 3187 | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-07-17T11:55:29.587000-04:00 | ||
| 1266169 | FABIANI & COMPANY 4490dae3-6ebf-44d8-b2a3-896f1384c19d | Q2 | FABIANI & COMPANY | 72576 | ACORDA THERAPEUTICS, INC. | 2012 | second_quarter | MED | Educate staff about Acordas products and research interests. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-07-17T13:09:51.487000-04:00 | |
| 1266176 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 79271210-134a-4b94-aac8-083981f42251 | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ONYX PHARMACEUTICALS | 2012 | second_quarter | MED | Innovation in biotechnology; patient access to treatments; FDA accelerated approval process; orphan drugs for rare diseases, health disparities, drug shortages. HR 4132 Faster Access to Specialized Treatments (FAST) Act; S.2113 Transforming the Regulatory Environment to Accellerate Access to Treatments (TREAT) Act; HR 2245/S.296: Preserving Access to Lifesaving Medications Act; S.3187, Food and Drug Administration Safety and Innovation Act | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2012-07-17T13:09:54.003000-04:00 | |
| 1266231 | VAN SCOYOC ASSOCIATES ba191897-24f8-4a03-a4f9-0b194e887668 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | TULANE UNIVERSITY | 2012 | second_quarter | MED | No lobbying activity. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-17T13:19:21.750000-04:00 | |
| 1266266 | FABIANI & COMPANY 3a23fbcd-0e8e-403a-8a8c-fa8362cf092c | Q2 | FABIANI & COMPANY | 72576 | MEDICAGO INC. | 2012 | second_quarter | MED | Funding to advance technology to support public health preparedness applications. | Defense, Dept of (DOD) | 30000 | 0 | 0 | 2012-07-17T13:24:41.677000-04:00 | |
| 1266343 | MCDERMOTT WILL & SCHULTE LLP a8570a0a-4c86-43cf-beaa-ca89ca279fe9 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | COALITION FOR 21ST CENTURY MEDICINE | 2012 | second_quarter | MED | Issues concerning regulation of laboratory tests. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-07-17T13:38:20.117000-04:00 | |
| 1266380 | MCDERMOTT WILL & SCHULTE LLP f55ce1d5-1418-4833-95d3-44cf388b9112 | Q2 | MCDERMOTT WILL & SCHULTE LLP | 24338 | GENOMIC HEALTH INC | 2012 | second_quarter | MED | FDA regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-07-17T13:47:41.600000-04:00 | |
| 1266870 | TCH GROUP, LLC 66c8540e-a000-4105-ad84-19be7bd39ac7 | Q2 | TCH GROUP, LLC | 51478 | AMGEN USA INC | 2012 | second_quarter | MED | Reauthorization of the Prescription Drug User Fee Act (PDUFA) | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-07-17T15:39:51.517000-04:00 | |
| 1267011 | FABIANI & COMPANY 6cf9d96f-a604-43c7-9b03-82677433ceb7 | 2T | FABIANI & COMPANY | 72576 | TARAXOS | 2012 | second_quarter | MED | Clinical research supporting development of topical pain medication for the DoD and veteran populations. | Veterans Affairs, Dept of (VA) | 0 | 1 | 2012-07-17T16:03:50.563000-04:00 | ||
| 1267103 | LATHAM & WATKINS LLP 2b6d65c5-d0cd-4398-82e3-83d53acc90a6 | Q2 | LATHAM & WATKINS LLP | 22201 | BOSTON SCIENTIFIC CORPORATION | 2012 | second_quarter | MED | Congressional oversight of the Food and Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-07-17T16:20:32.937000-04:00 | |
| 1267386 | WHITMER & WORRALL, LLC 30208b09-8dd7-4c1c-8ff3-f37913270f9b | Q2 | WHITMER & WORRALL, LLC | 292892 | NEURO KINETICS | 2012 | second_quarter | MED | Issues related to Traumatic Brain Injury (TBI). | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2012-07-17T17:00:46.267000-04:00 | |
| 1267442 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 4bce38f8-6d57-4221-8dd2-de8cf637c9fd | Q2 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | CRESCENDO BIOSCIENCE INC. | 2012 | second_quarter | MED | Biomedical research, treatment of rheumatoid arthritis, public-private partnerships, oversight and reimbursement of laboratory testing. HR 436, Protect Medical Innovation Act | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2012-07-17T17:09:13.237000-04:00 | |
| 1267810 | NATIONAL PSORIASIS FOUNDATION 2924ad01-c472-4907-8cd2-5b045940efe8 | Q2 | NATIONAL PSORIASIS FOUNDATION | 314658 | NATIONAL PSORIASIS FOUNDATION | 2012 | second_quarter | MED | H.R.2033: The Psoriasis and Psoriatic Arthritis Research, Cure and Care Act of 2011 S.1107: The Psoriasis and Psoriatic Arthritis Research, Cure and Care Act of 2011 SEC. 3. NATIONAL PSORIASIS AND PSORIATIC ARTHRITIS DATA COLLECTION. (a) In General- The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, is authorized to undertake psoriasis and psoriatic arthritis data collection efforts, including incorporating questions into public health surveys, questionnaires, and other databases in existence as of the date of the enactment of this Act to collect information, with respect to psoriasis and psoriatic arthritis, regarding-- (1) the prevalence of psoriasis and psoriatic arthritis in the United States; (2) the age of onset; (3) health-related quality of life; (4) health care utilization; (5) burden of such disease (such as with respect to employment); (6) direct and indirect costs; (7) health disparities, including with respect to age, gender, race, and ethnicity; and (8) comorbidities and the natural history of such disease. Such data collection efforts may include the consideration and development of a patient registry, which would include individuals of all ages. (b) Authorization of Appropriations- To carry out subsection (a), there are authorized to be appropriated $1,500,000 for each of fiscal years 2012 through 2017. SEC. 4. SENSE OF CONGRESS FOR COLLABORATIVE INTERDISCIPLINARY RESEARCH ON PSORIASIS AND PSORIATIC ARTHRITIS AND COMORBID CONDITIONS. It is the sense of the Congress that-- (1) the psoriasis research community has made significant strides in proving the seriousness of psoriasis as an autoimmune disease and in advancing the identification of commonalities between psoriasis and other diseases; (2) the nonprofit and private sector psoriasis research communities are to be commended for planning a multidisciplinary scientific meeting in 2012 to discuss future directions of psoriasis and comorbid research, identify initiatives nece… | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 120000 | 0 | 0 | 2012-07-17T19:14:13.607000-04:00 | |
| 1268049 | THE NORMANDY GROUP, LLC 5221d9ea-75f4-4235-9630-58b5908ffd49 | Q2 | THE NORMANDY GROUP, LLC | 306636 | CENTER FOR DISEASE DETECTION, LLC | 2012 | second_quarter | MED | Seek assistance from Dept. of Commerce, Dept. of State in effort to expand medical testing in foreign countries. | Commerce, Dept of (DOC),State, Dept of (DOS) | 30000 | 0 | 0 | 2012-07-18T09:25:26.163000-04:00 | |
| 1268123 | POLICY DIRECTIONS INC. 170322be-ea43-4edf-aa06-8e7fc48a453b | Q2 | POLICY DIRECTIONS INC. | 31747 | BAYLOR COLLEGE OF MEDICINE | 2012 | second_quarter | MED | S. 606 and HR 3059- Creating Hope Act of 2011 - issues related to neglected tropical disease research and treatment. HR 528 - Neglected Infections of Impoverished Americans Act of 2011. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-18T09:42:55.053000-04:00 | |
| 1268173 | POLICY DIRECTIONS INC. a75e217a-f202-4240-a32e-32c5257bd282 | Q2 | POLICY DIRECTIONS INC. | 31747 | COVANCE INC | 2012 | second_quarter | MED | No Bills. Issues related to FDA regulatory requirements for product testing. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-07-18T09:50:12.117000-04:00 | |
| 1268715 | FAEGRE BAKER DANIELS CONSULTING 9fe998bb-387e-4b41-8bea-dd7b1d8ecd79 | Q2 | FAEGRE BAKER DANIELS CONSULTING | 34158 | COALITION FOR EXCELLENCE IN MEDICATION MONITORING | 2012 | second_quarter | MED | Medicare and Medicaid coverage and payment | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-18T11:19:37.597000-04:00 | |
| 1268827 | FABIANI & COMPANY 2c69d66f-3f98-40b1-9292-5bc810218a8e | Q2 | FABIANI & COMPANY | 72576 | ZIOPHARM ONCOLOGY, INC. | 2012 | second_quarter | MED | Educated members of the House of Representatives on the importance of encouraging innovation in rare cancer drug development. | HOUSE OF REPRESENTATIVES | 50000 | 0 | 0 | 2012-07-18T11:32:26.947000-04:00 | |
| 1268930 | PARRY, ROMANI, DECONCINI & SYMMS 2fbc5189-4f74-4bea-a23c-57d7e3315b3f | Q2 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC ) | 2012 | second_quarter | MED | General discussions regarding the rauthorization of the Prescription Drug User Fee Act (PDUFA), S. 3187 and H.R. 5651; and education and awareness of vaccine production and infrastructure needs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-07-18T11:46:14.890000-04:00 | |
| 1269059 | DESIMONE CONSULTING, LLC 827f7025-0953-4ddd-8f2c-a34b2e2ac380 | Q2 | DESIMONE CONSULTING, LLC | 400931695 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2012 | second_quarter | MED | Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-07-18T12:00:56.457000-04:00 | |
| 1269958 | THE CORMAC GROUP, LLC 225a4edf-df46-4dee-9b2f-befc7ede85ea | Q2 | THE CORMAC GROUP, LLC | 66773 | MIAMI JEWISH HEALTH SYSTEMS | 2012 | second_quarter | MED | HHS Appropriations, health care facilities, IT funding for nursing homes, federal grants and veterans programs | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-07-18T14:07:46.337000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);